Fact EV/EBIT
Cos'è EV/EBIT di Fact?
EV/EBIT di Fact, Inc. è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Industrials settore su OTC rispetto a Fact
Cosa fa Fact?
Fact, Inc. engages in the art verification and authentication, sports memorabilia, and fine art businesses. It is developing a front-end user interface, as well as modifying existing ballistics firmware for a comprehensive verification, tracking, and reporting system using white light interferometry to take a non-destructive 3D digital fingerprint of the art using approximately 100,000 unique images. The company was formerly known as Tiburon International Trading Corp. and changed its name to Fact, Inc. in November 2020. FACT, Inc. is headquartered in Toronto, Canada. As of October 5, 2020, Fact, Inc. operates as a subsidiary of Kryptos Art Technologies, Inc.
Aziende con ev/ebit simili a Fact
- Frequency Exchange ha EV/EBIT di N/A
- Torstar ha EV/EBIT di N/A
- Miragen Therapeutics Inc ha EV/EBIT di N/A
- Mitesco ha EV/EBIT di N/A
- Monumental Minerals Corp ha EV/EBIT di N/A
- C4 Therapeutics ha EV/EBIT di N/A
- Fact ha EV/EBIT di N/A
- BioCardia ha EV/EBIT di N/A
- Comprehensive Healthcare Systems ha EV/EBIT di N/A
- Progenity ha EV/EBIT di N/A
- THC Therapeutics ha EV/EBIT di N/A
- RiceBran Technologies ha EV/EBIT di N/A
- BioAtla ha EV/EBIT di N/A